Hepatocellular carcinoma surveillance—Utilization, barriers and the impact of changing aetiology
Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …
part because of inadequate early detection strategies. Current recommendations for …
Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
The diagnosis and management of hepatocellular carcinoma (HCC) have improved
significantly in recent years. With the introduction of immunotherapy-based combination …
significantly in recent years. With the introduction of immunotherapy-based combination …
Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)
H You, FS Wang, T Li, X Xu, Y Sun, Y Nan… - Infectious Diseases & …, 2023 - mednexus.org
To facilitate the achieving of the goal of" eliminating viral hepatitis as a major public health
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …
Risk stratification and early detection biomarkers for precision HCC screening
Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …
consequence of failed early detection. Professional societies recommend semi‐annual HCC …
Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis
B Yu, W Ma - Cytokine & Growth Factor Reviews, 2024 - Elsevier
Hepatocellular carcinoma (HCC) is a leading contributor to cancer-related deaths worldwide
and presents significant challenges in diagnosis and treatment due to its heterogeneous …
and presents significant challenges in diagnosis and treatment due to its heterogeneous …
Updating the clinical application of blood biomarkers and their algorithms in the diagnosis and surveillance of hepatocellular carcinoma: a critical review
The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …
[HTML][HTML] Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
BN Toan, CK Tan, I Hasan, L Setiawan… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is
recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP …
recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP …
The performance of GALAD score for diagnosing hepatocellular carcinoma in patients with chronic liver diseases: a systematic review and meta-analysis
MC Guan, SY Zhang, Q Ding, N Li, TT Fu… - Journal of Clinical …, 2023 - mdpi.com
Background GALAD score, comprising five clinical parameters, is a predictive model
developed for hepatocellular carcinoma (HCC) detection. Since its emergence, its …
developed for hepatocellular carcinoma (HCC) detection. Since its emergence, its …
HES V2. 0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States
Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology Communications
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue …
Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get new issue …